Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MRK
Recent news which mentions MRK
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
What’s old is new again — the Dogs of the Dow are outperforming the stock market
January 28, 2022
Tickers
AAPL
AMC
AMD
AMGN
Tags
AAPL
NIO
KO
From
MarketWatch
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
Tickers
AMGN
BMY
CSCO
CVX
Tags
DOW
CSCO
DJD
From
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
Tickers
ABT
BNTX
BSX
JNJ
Tags
Options
SYRS
UNH
From
Benzinga
U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster
January 27, 2022
Tickers
MRK
MRNA
PFE
Tags
PFE
MRNA
MRK
From
MarketWatch
Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock
January 27, 2022
Tickers
IPOS
MRK
Tags
IPOs
Benzinga
News
From
Benzinga
Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer
January 27, 2022
Tickers
MRK
Tags
Health Care
Biotech
Market News
From
Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
Tickers
ARDS
ATAI
ATRA
CUE
Tags
ONCY
Offerings
GLPG
From
Benzinga
Cue Pharma Posts Two Responses From CUE-101 Combo In Head & Neck Cancer
January 27, 2022
Tickers
CUE
MRK
Tags
Benzinga
General
CUE
From
Benzinga
Vaccinex Posts Two Complete Responses In Pepinemab Combo Trial In Head & Neck Cancer
January 26, 2022
Tickers
MRK
VCNX
Tags
Penny Stocks
MRK
Biotech
From
Benzinga
2 Growth Stocks Down 21% to 39% That Could Soar, According to Wall Street
January 26, 2022
Tickers
DASH
LLY
MRK
VEEV
Tags
VRTX
DASH
VEEV
From
Motley Fool
2 Stocks to Buy No Matter What Happens in 2022
January 26, 2022
Tickers
AAPL
ABBV
BNTX
JNJ
Tags
TSM
JNJ
ABBV
From
Motley Fool
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
LLY
BNTX
MRK
From
MarketWatch
eFFECTOR Secures $50M Funding From Lincoln Park Capital
January 25, 2022
Tickers
EFTR
MRK
Tags
Biotech
Market News
MRK
From
Benzinga
These 4 Dow Stocks Are Screaming Buys in 2022
January 25, 2022
Tickers
CRM
DJI
MRK
V
Tags
V
MRK
Market News
From
Motley Fool
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
Antibodies
MRK
Omicron
From
Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
Tickers
AZN
LLY
MRK
PFE
Tags
PFE
Market News
MRK
From
Benzinga
Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients
January 24, 2022
Tickers
MRK
Tags
Health Care
COVID/19 Coronavirus
General
From
Benzinga
3 No-Brainer Healthcare Stocks to Buy Right Now for Less than $150
January 24, 2022
Tickers
ABBV
ABT
CVS
JPM
Tags
JPM
Market News
Recent Press Releases
From
Motley Fool
Merck's Gefapixant For Chronic Cough Slapped With FDA Complete Response Letter
January 24, 2022
Tickers
MRK
Tags
Benzinga
FDA
General
From
Benzinga
Benzinga Bulls And Bears Of The Past Week: ViacomCBS, Ford, Meta, Netflix, Microsoft, Tesla And More
January 22, 2022
Tickers
ADSK
ATVI
F
FB
Tags
Long Ideas
F
VIAC
From
Benzinga
Merck Scores Win In Insurance Battle Over Cyberattack - Bloomberg Report
January 21, 2022
Tickers
MRK
Tags
Market News
Biotech
Health Care
From
Benzinga
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
January 20, 2022
Tickers
BNTX
GILD
LLY
MRK
Tags
Benzinga
General
LLY
From
Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
Tickers
BNTX
GILD
GSK
MRK
Tags
BNTX
MRK
VIR
From
MarketWatch
We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone
January 20, 2022
Tickers
GILD
MRK
PFE
Tags
MRK
PFE
GILD
From
MarketWatch
Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag
January 20, 2022
Tickers
BOVNF
CASI
MRK
Tags
Health Care
General
FDA
From
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Tickers
ALKS
AMGN
ARGX
BGNE
Tags
ZYME
Market News
NVAX
From
Benzinga
Palantir’s Long-Term Bull Case Looks Compelling
January 19, 2022
Tickers
KMI
MRK
PLTR
Tags
KMI
Stocks to Buy
NYSE:PLTR,NYSE:MRK,NYSE:KMI
From
InvestorPlace
Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer
January 19, 2022
Tickers
MRK
SGEN
Tags
Biotech
Market News
Health Care
From
Benzinga
Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial
January 19, 2022
Tickers
MRK
Tags
Benzinga
Phase 3 Trial
FDA
From
Benzinga
3 Under-the-Radar COVID Stocks
January 19, 2022
Tickers
ABBV
AMGN
AZN
FIGS
Tags
LULU
NRXP
AMGN
From
Motley Fool
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.